NCT06905171

Brief Summary

The goal of this observational study is to assess event-related potentials and habituation in patients with fibromyalgia. The main research questions are:

  • Is there a measurable difference in sensory responses between fibromyalgia patients and healthy control?
  • Could these measures provide evidence supporting claims of hypersensitivity? Participants will: \- receive randomized sensory stimuli (auditory, visual, somatosensory, audiovisual, auditory-somatosensory, visual-somatosensory, and auditory-visual-somatosensory) in blocks of 20 trials.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 14, 2025

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

March 25, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2025

Completed
Last Updated

August 14, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

March 25, 2025

Last Update Submit

August 11, 2025

Conditions

Keywords

Event-Related PotentialsElectroencephalographyHabituation

Outcome Measures

Primary Outcomes (1)

  • Percentual Habituation

    Relative reduction in the amplitude of evoked potentials between consecutive stimuli

    Immediately after the intervention

Secondary Outcomes (9)

  • Fibromyalgia Impact Questionnaire-Revised version (FIQR)

    10 minutes before the intervention

  • Symptoms Impact Questionnaire (SIQ)

    10 minutes before the intervention

  • Hospital Anxiety and Depression Scale (HADS)

    10 minutes before the intervention

  • Numeric Rating Scale Pain (NRSp)

    10 minutes before the intervention

  • Stimulus saliency

    Immediately after the intervention

  • +4 more secondary outcomes

Study Arms (2)

Fibromyalgia Patients

Patients with primary fibromyalgia diagnosis. May include other chronic pain comorbidities, but the pain associated with those diseases should be less severe than the pain caused by fibromyalgia.

Other: Auditory StimulationOther: Visual StimulationOther: Somatosensory StimulationOther: Auditory-Visual StimulationOther: Visual-Somatosensory StimulationOther: Auditory-Somatonsensory StimulationOther: Auditory-Visual-Somatosensory Stimulation

Healthy Controls

Volunteers with no clinical history of chronic pain, musculoskeletal or articular disorders

Other: Auditory StimulationOther: Visual StimulationOther: Somatosensory StimulationOther: Auditory-Visual StimulationOther: Visual-Somatosensory StimulationOther: Auditory-Somatonsensory StimulationOther: Auditory-Visual-Somatosensory Stimulation

Interventions

A tone at a 1000 Hz frequency, delivered through speakers at a comfortable volume

Fibromyalgia PatientsHealthy Controls

A checkerboard pattern displayed on a monitor, with colors alternating every 25 ms

Fibromyalgia PatientsHealthy Controls

A train of three electrical stimuli, each lasting 1 ms, separated by 8 ms, at an intensity that clearly elicits a pricking sensation

Fibromyalgia PatientsHealthy Controls

Stimulation using auditory and visual stimuli concomitantly

Fibromyalgia PatientsHealthy Controls

Stimulation using visual and somatosensory stimuli concomitantly

Fibromyalgia PatientsHealthy Controls

Stimulation using auditory and somatosensory stimuli concomitantly

Fibromyalgia PatientsHealthy Controls

Stimulation using auditory, visual and somatosensory stimuli concomitantly

Fibromyalgia PatientsHealthy Controls

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The cohorts of patients and healthy controls wil be selected from the city of Paraná and surrounding areas. Through the ONG "Fibromialgia Entre Ríos Asociación Civil", the patients will be reached out and asked wether or not they are willing to participate. Additionally, flyer will be hung in major health facilities in the city and made public on social media. The cohort of healthy volunteers will be recruited after the patients for age, genre and socieconomic matching

You may qualify if:

  • Fibromyalgia patients:
  • Primary diagnosis of fibromyalgia according to the criteria used by the healthcare professional in charge of the patient.
  • Other comorbidities are accepted as long as the pain caused by them is less severe than the pain caused by fibromyalgia.
  • Willingness and ability to fully understand the content and scope of the experiment and to comply with the experiment instructions.
  • Normal or corrected-to-normal vision.
  • Normal hearing
  • Healthy controls:
  • No history of neurological diseases, chronic pain or musculoskeletal disorders.
  • Willingness and ability to fully understand the content and scope of the experiment and to comply with the experiment instructions.
  • Normal or corrected-to-normal vision.
  • Normal hearing

You may not qualify if:

  • Fibromyalgia patients:
  • Pregnancy
  • History of addictive behavior, defined as alcohol, cannabis, opioids or other drugs abuse.
  • Presence of fever, tuberculosis, malignant tumors, infectious processes, acute inflammatory processes.
  • Lack of cooperation
  • Healthy controls:
  • Pregnancy
  • History of chronic pain or musculoskeletal or articular disorders
  • History of addictive behavior, defined as alcohol, cannabis, opioids or other drugs abuse.
  • Presence of fever, tuberculosis, malignant tumors, infectious processes, acute inflammatory processes.
  • Lack of cooperation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Engineering-National University of Entre Ríos

Oro Verde, Entre Ríos Province, 3100, Argentina

Location

Related Publications (10)

  • Gondan M, Roder B. A new method for detecting interactions between the senses in event-related potentials. Brain Res. 2006 Feb 16;1073-1074:389-97. doi: 10.1016/j.brainres.2005.12.050. Epub 2006 Jan 20.

    PMID: 16427613BACKGROUND
  • Thompson RF, Spencer WA. Habituation: a model phenomenon for the study of neuronal substrates of behavior. Psychol Rev. 1966 Jan;73(1):16-43. doi: 10.1037/h0022681. No abstract available.

    PMID: 5324565BACKGROUND
  • Montoya P, Sitges C, Garcia-Herrera M, Rodriguez-Cotes A, Izquierdo R, Truyols M, Collado D. Reduced brain habituation to somatosensory stimulation in patients with fibromyalgia. Arthritis Rheum. 2006 Jun;54(6):1995-2003. doi: 10.1002/art.21910.

    PMID: 16732548BACKGROUND
  • Lorenz J. Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol. 1998;57 Suppl 2:19-22. doi: 10.1007/s003930050228.

    PMID: 10025076BACKGROUND
  • de Tommaso M, Federici A, Santostasi R, Calabrese R, Vecchio E, Lapadula G, Iannone F, Lamberti P, Livrea P. Laser-evoked potentials habituation in fibromyalgia. J Pain. 2011 Jan;12(1):116-24. doi: 10.1016/j.jpain.2010.06.004. Epub 2010 Aug 4.

    PMID: 20685171BACKGROUND
  • Alanoglu E, Ulas UH, Ozdag F, Odabasi Z, Cakci A, Vural O. Auditory event-related brain potentials in fibromyalgia syndrome. Rheumatol Int. 2005 Jun;25(5):345-9. doi: 10.1007/s00296-004-0443-3. Epub 2004 Feb 21.

    PMID: 14986061BACKGROUND
  • McDermid AJ, Rollman GB, McCain GA. Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain. 1996 Aug;66(2-3):133-44. doi: 10.1016/0304-3959(96)03059-x.

    PMID: 8880834BACKGROUND
  • Young EL, Mista CA, Jure FA, Andersen OK, Biurrun Manresa JA. An analytical method to separate modality-specific and nonspecific sensory components of event-related potentials. Eur J Neurosci. 2022 Oct;56(7):5090-5105. doi: 10.1111/ejn.15798. Epub 2022 Aug 31.

    PMID: 35983754BACKGROUND
  • Staud R, Godfrey MM, Robinson ME. Fibromyalgia Patients Are Not Only Hypersensitive to Painful Stimuli But Also to Acoustic Stimuli. J Pain. 2021 Aug;22(8):914-925. doi: 10.1016/j.jpain.2021.02.009. Epub 2021 Feb 23.

    PMID: 33636370BACKGROUND
  • Lim M, Roosink M, Kim JS, Kim HW, Lee EB, Son KM, Kim HA, Chung CK. Augmented Pain Processing in Primary and Secondary Somatosensory Cortex in Fibromyalgia: A Magnetoencephalography Study Using Intra-Epidermal Electrical Stimulation. PLoS One. 2016 Mar 18;11(3):e0151776. doi: 10.1371/journal.pone.0151776. eCollection 2016.

    PMID: 26992095BACKGROUND

MeSH Terms

Conditions

FibromyalgiaSubstance-Related Disorders

Interventions

Acoustic StimulationPhotic Stimulation

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TherapeuticsSensory Art TherapiesComplementary TherapiesPhysical StimulationInvestigative Techniques

Study Officials

  • Biurrun Manresa

    National Council of Scientific and Technical Research, Argentina (CONICET)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

March 25, 2025

First Posted

April 1, 2025

Study Start

March 14, 2025

Primary Completion

May 16, 2025

Study Completion

May 16, 2025

Last Updated

August 14, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Individual participant data (IPD) will be made available on the 'Open Science Framework' after undergoing the process of anonymization to remove any participant-identifying information. The data will consist of the raw EEG signals and raw behavioral responses to cognitive tasks. Additionally, the statistical analysis and Jupyter notebooks used to process the data will also be shared

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
The participant's data and the processing pipeline will be available after the data collection is finished. The supporting information (including the study protocol, the statistical analysis plan and the informed consent) will be uploaded as soon as possible.
Access Criteria
The data will be publicly available.

Locations